Richard Powers

Jan 23, 2025 | pymnts.com | Richard Powers

Over the last several years, the U.S. Department of Justice’s Antitrust Division (“the Division”) has deployed new strategies for combating cartels through updates to its leniency program and compliance guidance as well as emphasizing other detection methods such as whistleblowers and complainants. The overarching theme of these changes is increasing the risk of detection by developing investigations outside of leniency while tightening the standards for getting leniency to include...

Sep 28, 2024 | socialnews.xyz | Richard Powers

perm_identityPersonalised advertising and content, advertising and content measurement, audience research and services developmentdevicesStore and/or access information on a deviceYou can choose how your personal data is used.

Feb 6, 2024 | lexology.com | Tobias Caspary |Neda Moussavi |Nathaniel L. Asker |Aleksandr B. Livshits |Richard Powers

In recent years, there has been a global shift towards tougher merger control, new theories of harm, more expansive regimes, and more regulatory hurdles emerging. It’s no surprise that once esoteric phrases like “killer acquisitions,” “competence creep” and “behavioural remedies” are entering the mainstream lexicon.

Jan 31, 2024 | lexology.com | Richard Powers |Nathaniel L. Asker |Aleksandr B. Livshits |Nathaniel Bronstein

The Antitrust Division and FTC have updated language[1] in document requests that now specifically references ephemeral and non-ephemeral messaging applications from both company- and employee-owned devices, as well as collaborative tools, as the types of applications that must be preserved and searched.

Sep 13, 2023 | lexology.com | Richard Powers |Aleksandr B. Livshits

Recent enforcement efforts by the DOJ and FTC show that the healthcare sector is under heightened scrutiny from US competition authorities. In 2021, the Biden administration issued an Executive Order on Promoting Competition in the American Economy, which directed federal agencies to take a number of steps to address perceived competitive harm occurring in the sector. Against this backdrop, here are the top four antitrust issues impacting the healthcare industry today.